CANCER

Steve Jobs Departure: Apple Stock will Return to Healthy Zone Soon

Steve Jobs
Apple stock fell over 7 percent in a single day of trading after it was announced that Steve Jobs was stepping down from the position of CEO. It was already expected that he would quit the position particularly with the confirmation of his health problem relating to pancreatic cancer. It was also expected that the stock of Apple was going to be badly hit once he officially made that decision. The one question remaining was how badly it was going to hit the shares of Apple. The trend shown last d...

Radio-Protective Melanin Viable For Space Science

Radio Protective Melanin Seen Viable For Space Science
Researchers at the U.S. Department of Energy's Savannah River National Laboratory (SRNL) have studied aspects of melanin’s radio-protective properties, which is a breakthrough for future biomimetic material. Scientists are now probing melanin’s self-restorative and radio-protective properties for space science.
Apple's Steve Jobs

Steve Jobs Resigns as Apple CEO, Will Continue as Board Chairman

Steve Jobs, co-founder of Apple Inc., resigned as chief executive officer, but will continue at the company that revolutionized consumer electronics as chairman of the board, according to reports. Jobs tendered his resignation on Wednesday, ending a 14-year reign at Apple, a tech-giant company that he co-founded in a garage.
More news
Study Doubts FDA'S Anti-Smoking Label Campaign

Usefulness of Grim Anti-Smoking Warnings Doubted

Mandatory anti-smoking warnings on U.S. cigarette packs are being challenged, this time by researchers who say the combination of grotesque images and explicit messages may not be effective in curbing smoking.
IBTimes Logo

Doctor Sued By Penis Amputee After Surgery, Trial Ends

A lawyer representing the Kentucky man who testified against Dr. John Patterson in the Shelby County Circuit Court, the doctor who amputated Seaton's penis without asking his permission, told jurors on Monday his client doesn't feel like a man.
NDP leader Jack Layton dies

NDP leader Jack Layton dies

Jack Layton, the charismatic leader of the New Democratic Party, died on Monday just months after guiding his party to its strongest ever performance in the May federal election.
IBTimes Logo

Bone drug tied to lower colon cancer risk

A new study adds to evidence that bone drugs may play a role in suppressing cancer development, although there is still no proof that taking the medications would stave off malignancies.
Jack Layton Dies

Jack Layton Dies at Age 61

Canadian opposition leader Jack Layton died early Monday morning after battling cancer. He was 61 years old.
Tanning Bed

FDA Approves 'Revolutionary' Melanoma Treatment

The U.S. Food and Drug Administration (FDA) Wednesday approved the Roche-manufactured drug Zelboraf, for the first-line treatment of both metastatic and unresectable types of melanoma, reportedly the most dangerous type of skin cancer.
Drug shortage

U.S. Vital Medicine Shortage Underscores Need for National Stockpile

U.S. Government officials and Congressional lawmakers, along with drug industry and doctors' groups, are scrambling to find remedies for critical shortages in a number of drugs that treat life-threatening illnesses, including bacterial infection and several forms of cancer.
Ketamine

Dance Club Drug Ecstasy Developed to Cure Cancer

Scientists from the University of Birmingham found that a modified form of Ecstasy (MDMA) could be used in treating myeloma, lymphoma, and leukemia, after scientists modified the drug to increase its tumour-killing properties.
IBTimes Logo

Seattle Genetics: FDA Approves Adcetris to Treat Lymphomas

Adcetris is an antibody-drug that targets a type of lymphoma cell called CD30. It is the first treatment approved by the FDA for fighting Hodgkin lymphoma since 1977, and also the first made to specifically treat anaplastic large cell lymphoma.
IBTimes Logo

Adcetris Gets FDA Approval to Treat 2 Types of Lymphoma

Adcetris is the first treatment for fighting Hodgkin lymphoma approved by the FDA since 1977, and the first specifically made to treat anaplastic large cell lymphoma. The drug is marketed by Seattle Genetics of Bothell, Wash.
Ketamine

Modified Ecstasy May Help Treat Cancer: Study

Researchers at the University of Birmingham have discovered that a modified version of Ecstasy (MDMA) may have great cancer-busting potential, fighting off myeloma, lymphoma, and leukemia.

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.